
8037.HK Technical Analysis Summary (HKSE)
Analyze 8037.HK on the HKSE with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer8037.HK Technical Analysis Summary (HKSE)
China Biotech Services Holdings Limited (HKSE: 8037.HK) stock currently shows a neutral trend on the HKSE, supported by momentum and balanced buying pressure.
Technical conditions suggest China Biotech Services Holdings Limited on the HKSE is awaiting a decisive move. Overall, China Biotech Services Holdings Limited remains neutral, with indicators showing mixed momentum.
RSI (14): 49.44
Stochastic %K: 19.69
Williams %R: -77.78
Rate of Change (ROC): -1.59
Takeaway:China Biotech Services Holdings Limited shows weakening momentum, with sellers gaining the edge.
MACD: 0.00
ADX: 25.23
ATR (14): 0.04
CCI (14): -48.84
Takeaway:China Biotech Services Holdings Limited shows weakening trend signals, with bearish pressure building.
Takeaway:China Biotech Services Holdings Limited trades closer to support, showing weaker momentum within bands.
Takeaway:China Biotech Services Holdings Limited trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:8037.HK shows oversold money flow, with rebound potential building.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for China Biotech Services Holdings Limited are mixed, suggesting a Hold or wait-and-see approach.